...
首页> 外文期刊>Journal of pediatric endocrinology & metabolism: JPEM >Novel growth hormone receptor gene mutation in a patient with Laron syndrome.
【24h】

Novel growth hormone receptor gene mutation in a patient with Laron syndrome.

机译:Laron综合征患者的新型生长激素受体基因突变。

获取原文
获取原文并翻译 | 示例
           

摘要

Growth Hormone (GH) is a 22 kDa protein that has effects on growth and glucose and fat metabolisms. These effects are initiated by binding of growth hormone (GH) to growth hormone receptors (GHR) expressed in target cells. Mutations or deletions in the growth hormone receptor cause an autosomal disorder called Laron-type dwarfism (LS) characterized by high circulating levels of serum GH and low levels of insulin like growth factor-1 (IGF-1). We analyzed the GHR gene for genetic defect in seven patients identified as Laron type dwarfism. We identified two missense mutations (S40L and W104R), and four polymorphisms (S473S, L526I, G168G and exon 3 deletion). We are reporting a mutation (W104R) at exon 5 of GHR gene that is not previously reported, and it is a novel mutation.
机译:生长激素(GH)是一种22 kDa的蛋白质,对生长以及葡萄糖和脂肪代谢有影响。这些作用是通过生长激素(GH)与靶细胞中表达的生长激素受体(GHR)结合而开始的。生长激素受体的突变或缺失会导致常染色体疾病,称为Laron型矮化症(LS),其特征是血清GH的循环水平高和胰岛素样生长因子-1(IGF-1)的水平低。我们分析了七名被确定为Laron型侏儒症患者的GHR基因遗传缺陷。我们确定了两个错义突变(S40L和W104R),和四个多态性(S473S,L526I,G168G和外显子3缺失)。我们报道了以前没有报道的GHR基因第5外显子的突变(W104R),这是一个新的突变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号